Hänvisningar gällande denna post

APA-referens (7:e uppl.)
Signorelli, C., Calegari, M. A., Basso, M., Anghelone, A., Lucchetti, J., Minelli, A., . . . Ruggeri, E. M. (2023). Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study. MDPI AG.
Chicago-referens (17:e uppl.)
Signorelli, Carlo, et al. Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and Beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study. MDPI AG, 2023.
MLA-referens (9:e uppl.)
Signorelli, Carlo, et al. Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and Beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study. MDPI AG, 2023.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.